420 Investor’s Alan Brochstein, On Recent Bull Run In Cannabis Stocks, Tells Benzinga Tilray, Cronos & Canopy Growth Benefit Disproportionately From U.S. Listing Status, Adds Those Cos. ‘Seem expensive to me. Tilray, especially, with its very tight float’